Genetic Polymorphisms in the mEH Gene in Relation to Tobacco Smoking: Role in Lung Cancer Susceptibility and Survival in North Indian Patients with Lung Cancer Undergoing Platinum-Based Chemotherapy

References

• Bray F , FerlayJ, SoerjomataramI, SiegelRL, TorreLA, JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.68(6), 394–424 (2018).
   PubMed Web of Science ®Google Scholar
• Winkler V , OttJJ, CowanM, BecherH. Smoking prevalence and its impacts on lung cancer mortality in Sub-Saharan Africa: an epidemiological study. Prev. Med.57(5), 634–640 (2013).
   PubMed Web of Science ®Google Scholar
• Kim JH , ParkK, YimSHet al. Genome-wide association study of lung cancer in Korean non-smoking women. J. Korean Med. Sci.28(6), 840–847 (2013).
   PubMed Web of Science ®Google Scholar
• Fretland AJ , OmiecinskiCJ. Epoxide hydrolases: biochemistry and molecular biology. Chem. Biol. Interact.129(1–2), 41–59 (2000).
   PubMed Web of Science ®Google Scholar
• Newman JW , MorisseauC, HammockBD. Epoxide hydrolases: their roles and interactions with lipid metabolism. Prog. Lipid Res.44(1), 1–51 (2005).
   PubMed Web of Science ®Google Scholar
• Tan X , WangYY, ChenXYet al. Quantitative assessment of the effects of the EPHX1 Tyr113His polymorphism on lung and breast cancer. Genet. Mol. Res.13, 7437–7446 (2014).
   PubMed Web of Science ®Google Scholar
• Yu W , LinZ, QuB. Impact of epoxide hydrolase 1 polymorphisms on lung cancer susceptibility in Asian populations. Cell Biochem. Biophy.71(2), 813–820 (2015).
   PubMed Web of Science ®Google Scholar
• Coller JK , FritzP, ZangerUMet al. Distribution of microsomal epoxide hydrolase in humans: an immunohistochemical study in normal tissues, and benign and malignant tumours. Histochem. J.33(6), 329–336 (2001).
   PubMedGoogle Scholar
• Skjelbred CF , SvendsenM, HauganVet al. Influence of GSTM1, GSTT1, GSTP1, NAT1, NAT2, EPHX1, MTR and MTHFR polymorphism on chromosomal aberration frequencies in human lymphocytes. Carcinogenesis32(3), 399–405 (2011).
   PubMed Web of Science ®Google Scholar
• Hassett C , AlcherL, SidhuJS, OmieclnsklCJ. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum. Mol. Genet.3(3), 421–428 (1994).
   PubMed Web of Science ®Google Scholar
• Lin TS , HuangHH, FanYH, ChiouSH, ChowKC. Genetic polymorphism and gene expression of microsomal epoxide hydrolase in non-small cell lung cancer. Oncol. Rep.17(3), 565–572 (2007).
   PubMed Web of Science ®Google Scholar
• Mittal RD , SrivastavaDL. Cytochrome P4501A1 and microsomal epoxide hydrolase gene polymorphisms: gene–environment interaction and risk of prostate cancer. DNA Cell Biol.26(11), 791–798 (2007).
   PubMed Web of Science ®Google Scholar
• Gsur A , ZidekT, SchnattingerKet al. Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk. Br. J. Cancer89(4), 702–706 (2003).
   PubMed Web of Science ®Google Scholar
• Erkisi Z , Yaylim-EraltanI, TurnaA, GörmüsU, CamlicaH, IsbirT. Polymorphisms in the microsomal epoxide hydrolase gene: role in lung cancer susceptibility and prognosis. Tumor J.96(5), 756–763 (2010).
   PubMed Web of Science ®Google Scholar
• Lee WJ , BrennanP, BoffettaPet al. Microsomal epoxide hydrolase polymorphisms and lung cancer risk: a quantitative review. Biomarkers7(3), 230–241 (2002).
   PubMed Web of Science ®Google Scholar
• Kiyohara C , YoshimasuK, TakayamaK, NakanishiY. EPHX1 26 polymorphisms and the risk of lung cancer: a HuGE review. Epidemiology17, 89–99 (2006).
   PubMed Web of Science ®Google Scholar
• Timofeeva M , KroppS, SauterWet al. Genetic polymorphisms of MPO, GSTT1, GSTM1, GSTP1, EPHX1 and NQO1 as risk factors of early-onset lung cancer. Int. J. Cancer127(7), 1547–1561 (2010).
   PubMed Web of Science ®Google Scholar
• Wang S , ZhuJ, ZhangR, WangS, GuZ. Association between microsomal epoxide hydrolase1 T113C polymorphism and susceptibility to lung cancer. Tumor Biol.34(2), 1045–1052 (2013).
   PubMedGoogle Scholar
• Gottlieb N . Indian cigarettes gain popularity, but don’t let the flavor fool you. J. Natl Cancer Inst.91, 1806–1807 (1999).
   PubMed Web of Science ®Google Scholar
• Behera D , BalamugeshT. Lung cancer in India. Indian J. Chest Dis. Allied Sci.46, 269–281 (2004).
   PubMedGoogle Scholar
• Tilak AR , KumarS, JainMet al. Association of functionally important polymorphism of microsomal epoxide hydrolase gene (EPHX1) with lung cancer susceptibility. Cancer Investig.29(6), 411–418 (2011).
   PubMed Web of Science ®Google Scholar
• Bahl C , SharmaS, SinghN, BeheraD. Association study between genetic variations in Axin2 gene and lung cancer risk in North Indian population: a multiple interaction analysis. Tumor Biol.39(4), 1–18 (2017).
   Google Scholar
• Zhou W , ThurstonSW, LiuGet al. The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer. Cancer Epidemiol. Biomarkers Prev.10(5), 461–466 (2001).
   PubMed Web of Science ®Google Scholar
• Ghattas MH , AmerMA. Possible role of microsomal epoxide hydrolase gene polymorphism as a risk factor for developing insulin resistance and type 2 diabetes mellitus. Endocrine42(3), 577–583 (2012).
   PubMed Web of Science ®Google Scholar
• Gresner P , GromadzinskaJ, WasowiczW. Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer. Lung Cancer57(1), 1–25 (2007).
   PubMed Web of Science ®Google Scholar
• To-Figueras J , GenéM, Gómez-CatalánJ, PiquéE, BorregoN, CorbellaJ. Lung cancer susceptibility in relation to combined polymorphisms of microsomal epoxide hydrolase and glutathione S-transferase P1. Cancer Lett.173(2), 155–162 (2001).
   PubMed Web of Science ®Google Scholar
• Wu X , GwynK, AmosCI, MakanN, HongWK, SpitzMR. The association of microsomal epoxide hydrolase polymorphisms and lung cancer risk in African–Americans and Mexican–Americans. Carcinogenesis22(6), 923–928 (2001).
   PubMed Web of Science ®Google Scholar
• Park JY , ChenL, ElahiA, LazarusP, TockmanMS. Genetic analysis of microsomal epoxide hydrolase gene and its association with lung cancer risk. Eur. J. Cancer Prev.14(3), 223 (2005).
   PubMed Web of Science ®Google Scholar
• Rosenberger A , IlligT, KorbKet al. Do genetic factors protect for early onset lung cancer? A case control study before the age of 50 years. BMC Cancer8(1), 60 (2008).
   PubMedGoogle Scholar
• Graziano C , CominCE, CrisciCet al. Functional polymorphisms of the microsomal epoxide hydrolase gene: a reappraisal on a early-onset lung cancer patients series. Lung Cancer63(2), 187–193 (2009).
   PubMed Web of Science ®Google Scholar
• Ihsan R , ChauhanPS, MishraAKet al. Multiple analytical approaches reveal distinct gene-environment interactions in smokers and non-smokers in lung cancer. PLoS ONE6(12), e29431 (2011).
   PubMed Web of Science ®Google Scholar
• Fathy M , HamedM, YoussifO, FawzyN, AshourW. Association between environmental tobacco smoke exposure and lung cancer susceptibility: modification by antioxidant enzyme genetic polymorphisms. Mol. Diagn. Ther.18(1), 55–62 (2014).
   PubMed Web of Science ®Google Scholar
• Zhao H , SpitzMR, GwynKM, WuX. Microsomal epoxide hydrolase polymorphisms and lung cancer risk in non-Hispanic whites. Mol. Carcinog.33, 99–104 (2002).
   PubMed Web of Science ®Google Scholar
• Cajas-Salazar N , AuWW, ZwischenbergerJBet al. Effect of epoxide hydrolase polymorphisms on chromosome aberrations and risk for lung cancer. Cancer Genet. Cytogen.145(2), 97–102 (2003).
   PubMedGoogle Scholar
• Persson I , JohanssonI, YueQY, DuanLS, BertilssonL, Ingelman-SundbergM. Genetic polymorphism of xenobiotic metabolising enzymes among Chinese lung cancer patients. Int. J. Cancer81(3), 325–329 (1999).
   PubMed Web of Science ®Google Scholar
• Voho A , MetsolaK, AnttilaSet al. EPHX1 gene polymorphisms and individual susceptibility to lung cancer. Cancer Lett.237(1), 102–108 (2006).
   PubMed Web of Science ®Google Scholar
• Yin L , PuY, LiuTY, TungYH, ChenKW, LinP. Genetic polymorphisms of NAD (P) H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China. Lung Cancer33(2–3), 133–141 (2001).
   PubMed Web of Science ®Google Scholar
• Liu H , LiHY, ChenHJ, HuangYJ, ZhangS, WangJ. EPHX1 A139G polymorphism and lung cancer risk: a meta-analysis. Tumor Biol.34(1), 155–163 (2013).
   PubMedGoogle Scholar
• Zienolddiny S , CampaD, LindHet al. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers. Carcinogenesis29(6), 1164–1169 (2008).
   PubMed Web of Science ®Google Scholar
• Hoffmann D , HoffmannI. The changing cigarette, 1950–1995. J. Toxicol. Environ. Health50, 307–364 (1997).
   PubMed Web of Science ®Google Scholar
• Alberg AJ , BrockMV, SametJM. Epidemiology of lung cancer: looking to the future. J. Clin. Oncol.10, 3175–3185 (2005).
   Google Scholar
• Subramanian J , GovindanR. Lung cancer in never smokers: a review. J. Clin. Oncol.25, 561–570 (2007).
   PubMed Web of Science ®Google Scholar
• London SJ , SmartJ, DalyAK. Lung cancer risk in relation to genetic polymorphisms of microsomal epoxide hydrolase among African-Americans and Caucasians in Los Angeles County. Lung Cancer28, 147–155 (2000).
   PubMed Web of Science ®Google Scholar
• Lee J , DahlM, NordestgaardBG. Genetically lowered microsomal epoxide hydrolase activity and tobacco-related cancer in 47,000 individuals. Cancer Epidemiol. Biomarkers Prev.20(8), 1673–1682 (2011).
   PubMed Web of Science ®Google Scholar
• Benhamou S , ReinikainenM, BouchardyCet al. Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Res.58, 5291–5293 (1998).
   PubMed Web of Science ®Google Scholar
• Lin P , WangSL, WangHJet al. Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma. Br. J. Cancer82(4), 852–857 (2000).
   PubMed Web of Science ®Google Scholar